Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12
Jaime Ibarrola, Rafael Sadaba, Ernesto Martinez-Martinez, Amaia Garcia-Peña, Vanessa Arrieta, Virginia Alvarez, Amaya Fernández-Celis, Alicia Gainza, Victoria Cachofeiro, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Frederic Jaisser, Natalia Lopez-Andres, Jaime Ibarrola, Rafael Sadaba, Ernesto Martinez-Martinez, Amaia Garcia-Peña, Vanessa Arrieta, Virginia Alvarez, Amaya Fernández-Celis, Alicia Gainza, Victoria Cachofeiro, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Frederic Jaisser, Natalia Lopez-Andres
Abstract
Aldosterone (Aldo) contributes to mitochondrial dysfunction and cardiac oxidative stress. Using a proteomic approach, A-kinase anchor protein (AKAP)-12 has been identified as a down-regulated protein by Aldo in human cardiac fibroblasts. We aim to characterize whether AKAP-12 down-regulation could be a deleterious mechanism which induces mitochondrial dysfunction and oxidative stress in cardiac cells. Aldo down-regulated AKAP-12 via its mineralocorticoid receptor, increased oxidative stress and induced mitochondrial dysfunction characterized by decreased mitochondrial-DNA and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) expressions in human cardiac fibroblasts. CRISPR/Cas9-mediated knock-down of AKAP-12 produced similar deleterious effects in human cardiac fibroblasts. CRISPR/Cas9-mediated activation of AKAP-12 blunted Aldo effects on mitochondrial dysfunction and oxidative stress in human cardiac fibroblasts. In Aldo-salt-treated rats, cardiac AKAP-12, mitochondrial-DNA and PGC-1α expressions were decreased and paralleled increased oxidative stress. In myocardial biopsies from patients with aortic stenosis (AS, n = 26), AKAP-12, mitochondrial-DNA and PGC-1α expressions were decreased as compared to Controls (n = 13). Circulating Aldo levels inversely correlated with cardiac AKAP-12. PGC-1α positively associated with AKAP-12 and with mitochondrial-DNA. Aldo decreased AKAP-12 expression, impairing mitochondrial biogenesis and increasing cardiac oxidative stress. AKAP-12 down-regulation triggered by Aldo may represent an important event in the development of mitochondrial dysfunction and cardiac oxidative stress.
Conflict of interest statement
The authors declare no competing interests.
Figures
References
- Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 2009;71:177–203. doi: 10.1146/annurev.physiol.010908.163119.
- Aiba T, Tomaselli GF. Electrical remodeling in the failing heart. Curr. Opin. Cardiol. 2010;25:29–36. doi: 10.1097/HCO.0b013e328333d3d6.
- Pellegrini L, Scorrano L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ. 2007;14:1275–84. doi: 10.1038/sj.cdd.4402145.
- Yamagata K, et al. Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions. J. Am. Soc. Nephrol. 2002;13:1816–23. doi: 10.1097/01.ASN.0000019772.17954.F8.
- Morino K, et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 2005;115:3587–3593. doi: 10.1172/JCI25151.
- Ong SB, et al. Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury. Circulation. 2010;121:2012–2022. doi: 10.1161/CIRCULATIONAHA.109.906610.
- Viña J, et al. Mitochondrial biogenesis in exercise and in ageing☆. Adv. Drug Deliv. Rev. 2009;61:1369–1374. doi: 10.1016/j.addr.2009.06.006.
- De Vecchis R, Ariano C. Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials. Cardiovasc. Diagn. Ther. 2017;7:272–287. doi: 10.21037/cdt.2017.03.04.
- Martínez-Martínez E, et al. Galectin-3 Blockade Inhibits Cardiac Inflammation and Fibrosis in Experimental Hyperaldosteronism and HypertensionNovelty and Significance. Hypertension. 2015;66:767–775. doi: 10.1161/HYPERTENSIONAHA.115.05876.
- Somanna NK, et al. Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell. Signal. 2015;27:1928–1938. doi: 10.1016/j.cellsig.2015.07.001.
- Sun Y, et al. Aldosterone-Induced Inflammation in the Rat Heart. Am. J. Pathol. 2002;161:1773–1781. doi: 10.1016/S0002-9440(10)64454-9.
- Hafstad AD, Nabeebaccus AA, Shah AM. Novel aspects of ROS signalling in heart failure. Basic Res. Cardiol. 2013;108:359. doi: 10.1007/s00395-013-0359-8.
- Zhu C, et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ. Am. J. Pathol. 2011;178:2020–31. doi: 10.1016/j.ajpath.2011.01.029.
- Yuan Y, et al. Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic. Biol. Med. 2012;53:30–43. doi: 10.1016/j.freeradbiomed.2012.03.015.
- Perino A, Ghigo A, Scott JD, Hirsch E. Anchoring proteins as regulators of signaling pathways. Circ. Res. 2012;111:482–92. doi: 10.1161/CIRCRESAHA.111.262899.
- Zeng C, et al. AKAP150 mobilizes cPKC-dependent cardiac glucotoxicity. Am. J. Physiol. Endocrinol. Metab. 2014;307:E384–97. doi: 10.1152/ajpendo.00175.2014.
- Perrino C, et al. AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. Cardiovasc. Res. 2010;88:101–110. doi: 10.1093/cvr/cvq155.
- Adluri RS, et al. Thioredoxin 1 enhances neovascularization and reduces ventricular remodeling during chronic myocardial infarction: A study using thioredoxin 1 transgenic mice. J. Mol. Cell. Cardiol. 2011;50:239–247. doi: 10.1016/j.yjmcc.2010.11.002.
- Martínez-Martínez E, et al. Differential proteomics reveals S100-A11 as a key factor in aldosterone-induced collagen expression in human cardiac fibroblasts. J. Proteomics. 2017;166:93–100. doi: 10.1016/j.jprot.2017.07.011.
- Araujo CM, et al. Rapid effects of aldosterone in primary cultures of cardiomyocytes – do they suggest the existence of a membrane-bound receptor? J. Recept. Signal Transduct. 2016;36:435–444. doi: 10.3109/10799893.2015.1122042.
- Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007;8:939–944. doi: 10.1038/sj.embor.7401062.
- Xia W, Unger P, Miller L, Nelson J, Gelman IH. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res. 2001;61:5644–51.
- Cha J-H, et al. AKAP12 Mediates Barrier Functions of Fibrotic Scars during CNS Repair. PLoS One. 2014;9:e94695. doi: 10.1371/journal.pone.0094695.
- Choi YK, et al. AKAP12 Regulates Human Blood-Retinal Barrier Formation by Downregulation of Hypoxia-Inducible Factor-1. J. Neurosci. 2007;27:4472–4481. doi: 10.1523/JNEUROSCI.5368-06.2007.
- Kwon H-B, et al. AKAP12 regulates vascular integrity in zebrafish. Exp. Mol. Med. 2012;44:225. doi: 10.3858/emm.2012.44.3.017.
- Burnworth B, et al. SSeCKS sequesters cyclin D1 in glomerular parietal epithelial cells and influences proliferative injury in the glomerulus. Lab. Investig. 2012;92:499–510. doi: 10.1038/labinvest.2011.199.
- Weissmüller T, et al. HIF-dependent regulation of AKAP12 (gravin) in the control of human vascular endothelial function. FASEB J. 2014;28:256–64. doi: 10.1096/fj.13-238741.
- Selvaraju V, et al. Regulation of A-Kinase-Anchoring Protein 12 by Heat Shock Protein A12B to Prevent Ventricular Dysfunction Following Acute Myocardial Infarction in Diabetic Rats. J. Cardiovasc. Transl. Res. 2017;10:209–220. doi: 10.1007/s12265-017-9734-4.
- Arany Z, et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR- coactivator 1. Proc. Natl. Acad. Sci. 2006;103:10086–10091. doi: 10.1073/pnas.0603615103.
- Huss JM, Kelly DP. Mitochondrial energy metabolism in heart failure: a question of balance. J. Clin. Invest. 2005;115:547–555. doi: 10.1172/JCI24405.
- Fabregat-Andres O, et al. mRNA PGC-1α levels in blood samples reliably correlates with its myocardial expression: study in patients undergoing cardiac surgery. Anatol. J. Cardiol. 2016;16:622–629.
- Martínez-Martínez E, et al. Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts. Sci. Rep. 2017;7:12192. doi: 10.1038/s41598-017-12305-7.
- Calvier L, et al. Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis. Arterioscler. Thromb. Vasc. Biol. 2013;33:67–75. doi: 10.1161/ATVBAHA.112.300569.
- Calvier L, et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC. Heart Fail. 2015;3:59–67. doi: 10.1016/j.jchf.2014.08.002.
- Arrieta V, et al. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis. Clin. Sci. (Lond). 2017;131:935–949. doi: 10.1042/CS20170145.
Source: PubMed